Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer

Published:2021-02 Issue:2 Volume:39 Page:132.e1-132.e6
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Onishi Takehisa,Sekito Sho,Shibahara Takuji,Yabana Tadashi

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference17 articles.

1. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer;Alfred Witjes;Eur Urol,2017

2. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial;Bochner;Eur Urol,2015

3. Complications after robot-assisted radical cystectomy: results from the international robotic cystectomy consortium;Johar;Eur Urol,2013

4. Underutilization of radical cystectomy among patients diagnosed with clinical stage T2 muscle-invasive bladder cancer;Williams;Eur Urol Focus,2017

5. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review;Ploussard;Eur Urol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. For Which Patients Should Bladder Preservation Be Considered After a Complete Response to Neoadjuvant Chemotherapy;European Urology Focus;2023-11

2. A Systematic Review of Oncological Outcomes Associated with Bladder-sparing Strategies in Patients Achieving Complete Clinical Response to Initial Systemic Treatment for Localized Muscle-invasive Bladder Cancer;European Urology Oncology;2023-06

3. Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review;Journal of Clinical Medicine;2023-02-16

4. Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer: A Review of Literature;Frontiers in Oncology;2022-04-13